Diabetic retinopathy: Some cellular, molecular and therapeutic considerations

Any young ophthalmologist wishing to explore the scientific basis of ophthalmic disease could not adopt a better role model than William Bowman, who arguably was our most remarkable and pre-eminent clinician-scientist. In 1832, at the early age of 16 years, Bowman served as apprentice to the Birmingham surgeon Hodgson, with whom he developed his exceptional observational and recording skills. Later, as an anatomy demonstrator and medical student at King's College, London, he demonstrated his huge capacity for assembling, cataloguing and organising data, leading to the compilation of a comprehensive work on the anatomy and physiology of the body, a standard text at the time.1•2 Before long Bowman's insatiable appetite for discovery, coupled with the serendipitous acquisition of a new compound microscope, led him to explore the microanatomy of numerous human and vertebrate tissues and organs and indulge his passion for the meticulous and exact recording of his findings, often in breathtaking detail, given his tools at the time. He made many clinico-pathological correlations in diverse disease processes and elegantly documented, for the first time, structures in the eye and kidney which bear his name to this day. Bowman's ordered and disciplined approach to the analysis and documentation of his anatomical and pathological discoveries was matched only by a raft of innovations relating to the preservation and fixation of histological specimens which allowed him to survey the delicate and intricate tissues of the eye in unprecedented detail. He used the ' glycational' properties of syrup to stabilise and fixate the friable and unwieldy retina long before standard cross-linking techniques evolved and exploited agitational micro-dissection methods to separate the retinal microvascular from neural tissue more than a century in advance of trypsin digestion methods?

[1]  A. McElduff,et al.  Diabetes Control and Complications Trial , 1993 .

[2]  Alan W. Stitt,et al.  Stereological estimation of Weibel-Palade bodies in the retinal vasculature of normal and diabetic dogs. , 1994, Current eye research.

[3]  M. Mcdaniel,et al.  Prevention of Diabetic Vascular Dysfunction by Guanidines: Inhibition of Nitric Oxide Synthase Versus Advanced Glycation End-Product Formation , 1993, Diabetes.

[4]  T. Kern,et al.  Retinopathy in galactosemic dogs continues to progress after cessation of galactosemia. , 1995, Archives of ophthalmology.

[5]  R. Ramsay,et al.  Progression of diabetic retinopathy after pancreas transplantation for insulin-dependent diabetes mellitus. , 1988, The New England journal of medicine.

[6]  P. Beaumont,et al.  Glycogen Accumulation in Retinal Neurons and Glial Cells of Streptozotocin-diabetic Rats: Quantitative Electron Microscopy , 1974, Diabetes.

[7]  J. J. Wang,et al.  Prevalence and associations of epiretinal membranes. The Blue Mountains Eye Study, Australia. , 1997, Ophthalmology.

[8]  S. Rees,et al.  Nitric oxide synthase immunoreactivity and NADPH diaphorase staining are co-localised in neurons closely associated with the vasculature in rat and human retina , 1995, Brain Research.

[9]  Sandra R. Smith,et al.  An activated form of transforming growth factor beta is produced by cocultures of endothelial cells and pericytes. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[10]  D. Zack,et al.  Apoptosis in ocular disease: a molecular overview. , 1996, Ophthalmic genetics.

[11]  L. P. Aiello Vascular endothelial growth factor. 20th-century mechanisms, 21st-century therapies. , 1997, Investigative ophthalmology & visual science.

[12]  T. Lüscher,et al.  The vascular endothelium as a regulator of the ocular circulation: a new concept in ophthalmology? , 1994, Survey of ophthalmology.

[13]  Alan W. Stitt,et al.  Advanced glycation end products in vitreous: Structural and functional implications for diabetic vitreopathy. , 1998, Investigative ophthalmology & visual science.

[14]  L. Aiello,et al.  Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[15]  H. Thieme,et al.  Insulin-induced hyperpolarization in retinal capillary pericytes. , 1993, Investigative ophthalmology & visual science.

[16]  T. Lyons,et al.  Age-dependent increase in ortho-tyrosine and methionine sulfoxide in human skin collagen is not accelerated in diabetes. Evidence against a generalized increase in oxidative stress in diabetes. , 1997, The Journal of clinical investigation.

[17]  T. Kern,et al.  Progression of Incipient Diabetic Retinopathy During Good Glycemic Control , 1987, Diabetes.

[18]  M. Sanders The Bowman Lecture. Papilloedema: 'the pendulum of progress'. , 1998, Eye.

[19]  J. Baynes Role of Oxidative Stress in Development of Complications in Diabetes , 1991, Diabetes.

[20]  A. Barber,et al.  Astrocytes increase barrier properties and ZO-1 expression in retinal vascular endothelial cells. , 1997, Investigative ophthalmology & visual science.

[21]  D. Cogan,et al.  Retinal vascular patterns. VI. Mural cells of the retinal capillaries. , 1963, Archives of ophthalmology.

[22]  J. Bromberg Pancreatic and islet transplantation for diabetes. , 1993, The New England journal of medicine.

[23]  R. Janzer,et al.  Astrocytes induce blood–brain barrier properties in endothelial cells , 1987, Nature.

[24]  M. P. Carson,et al.  Junctional transfer of small molecules in cultured bovine brain microvascular endothelial cells and pericytes. , 1987, Microvascular research.

[25]  T. Lyons,et al.  Toxicity of Mildly Modified Low-Density Lipoproteins to Cultured Retinal Capillary Endothelial Cells and Pericytes , 1994, Diabetes.

[26]  G. Naumann The Bowman Lecture , 1995, Eye.

[27]  D. Eliott,et al.  Vascular endothelial growth factor is present in glial cells of the retina and optic nerve of human subjects with nonproliferative diabetic retinopathy. , 1997, Investigative ophthalmology & visual science.

[28]  G. Eisenbarth,et al.  Insulin prophylaxis in individuals at high risk of type 1 diabetes , 1993, The Lancet.

[29]  S. Bursell,et al.  Cellular and molecular abnormalities in the vascular endothelium of diabetes mellitus. , 1994, Annual review of medicine.

[30]  Norman Fleischer,et al.  The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. , 1993 .

[31]  J. Eichberg,et al.  Alterations in retinal Na+, K(+)-ATPase in diabetes: streptozotocin-induced and Zucker diabetic fatty rats. , 1993, Current eye research.

[32]  S. Bursell,et al.  The in vivo effect of endothelins on retinal circulation in nondiabetic and diabetic rats. , 1995, Investigative ophthalmology & visual science.

[33]  Donald E McMillan,et al.  The Effect of Diabetes on Blood Flow Properties , 1983, Diabetes.

[34]  G. Schmid-Schönbein,et al.  Activated monocytes and granulocytes, capillary nonperfusion, and neovascularization in diabetic retinopathy. , 1991, The American journal of pathology.

[35]  M. Sporn,et al.  Correlation of fibrosis and transforming growth factor-beta type 2 levels in the eye. , 1989, The Journal of clinical investigation.

[36]  S. Bursell,et al.  Correlation of diacylglycerol level and protein kinase C activity in rat retina to retinal circulation. , 1993, The American journal of physiology.

[37]  M. Lorenzi,et al.  Accelerated death of retinal microvascular cells in human and experimental diabetic retinopathy. , 1996, The Journal of clinical investigation.

[38]  R. Wright Vascular Permeability in Experimental Brain Tumors , 1967, Angiology.

[39]  D. Archer,et al.  Radiation retinopathy—Clinical, histopathological, ultrastructural and experimental correlations , 1991, Eye.

[40]  Chandra L. Theesfeld,et al.  Involvement of integrins alpha v beta 3 and alpha v beta 5 in ocular neovascular diseases. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[41]  S. Bursell,et al.  Amelioration of Vascular Dysfunctions in Diabetic Rats by an Oral PKC β Inhibitor , 1996, Science.

[42]  R. Robertson Pancreas Transplantation in Humans With Diabetes Mellitus , 1991, Diabetes.

[43]  S. Bursell,et al.  Retinal blood flow changes in patients with insulin-dependent diabetes mellitus and no diabetic retinopathy. , 1996, Investigative ophthalmology & visual science.

[44]  G. Palade,et al.  Increased microvascular permeability and endothelial fenestration induced by vascular endothelial growth factor. , 1995, Journal of cell science.

[45]  B. Reboussin,et al.  Antioxidant nutrient intake and diabetic retinopathy: the San Luis Valley Diabetes Study. , 1998, Ophthalmology.

[46]  E. Friedman,et al.  Advanced glycosylation end products in patients with diabetic nephropathy. , 1991, The New England journal of medicine.

[47]  J. Stone,et al.  Vascular endothelial growth factor acts as a survival factor for newly formed retinal vessels and has implications for retinopathy of prematurity , 1995, Nature Medicine.

[48]  R. Holman,et al.  Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. , 1998 .

[49]  G. King,et al.  Reversal of abnormal retinal hemodynamics in diabetic rats by acarbose, an alpha-glucosidase inhibitor. , 1995, Current eye research.

[50]  G. Jerums,et al.  Organ specificity of antihypertensive therapy on ocular albumin vascular clearance and albuminuria in the hypertensive diabetic rat. , 1996, Investigative ophthalmology & visual science.

[51]  D. Archer,et al.  The effect of endothelin 1 on the retinal microvascular pericyte. , 1992, Microvascular research.

[52]  B. Buckingham,et al.  Biochemical abnormalities in vitreous of humans with proliferative diabetic retinopathy. , 1992, Archives of ophthalmology.

[53]  W. Li,et al.  Expression of apoptosis regulatory genes by retinal pericytes after rapid glucose reduction. , 1998, Investigative ophthalmology & visual science.

[54]  C. Imrie,et al.  Pancreatic transplantation , 1990 .

[55]  J. Cockcroft,et al.  Vitamin E and cardiovascular protection in diabetes , 1997, BMJ.

[56]  T. Kern,et al.  Abnormalities of Retinal Metabolism in Diabetes or Experimental Galactosemia. III. Effects of Antioxidants , 1996, Diabetes.

[57]  J. Finlayson,et al.  High glucose downregulates glucose transport activity in retinal capillary pericytes but not endothelial cells. , 1994, Investigative ophthalmology & visual science.

[58]  G. Lubec,et al.  Reduced susceptibility of nonenzymatically glucosylated glomerular basement membrane to proteases: is thickening of diabetic glomerular basement membranes due to reduced proteolytic degradation? , 1980, Renal physiology.

[59]  M. Brownlee,et al.  Glycation Products and the Pathogenesis of Diabetic Complications , 1992, Diabetes Care.

[60]  Y. Hata,et al.  Vascular endothelial growth factor plays a role in hyperpermeability of diabetic retinal vessels. , 1995, Ophthalmic research.

[61]  T. Bensaoula,et al.  Captopril ameliorates the decreased Na+,K(+)-ATPase activity in the retina of streptozotocin-induced diabetic rats. , 1996, Investigative ophthalmology & visual science.

[62]  H. Dvorak,et al.  Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. , 1995, The American journal of pathology.

[63]  E. Keshet,et al.  Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis , 1992, Nature.

[64]  J. Caprioli,et al.  Hyperthermia and hypoxia increase tolerance of retinal ganglion cells to anoxia and excitotoxicity. , 1996, Investigative ophthalmology & visual science.

[65]  A. Cerami,et al.  Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications. , 1988, The New England journal of medicine.

[66]  J. Tarbell,et al.  Vascular permeability in experimental diabetes is associated with reduced endothelial occludin content: vascular endothelial growth factor decreases occludin in retinal endothelial cells. Penn State Retina Research Group. , 1998, Diabetes.

[67]  J. Simpson,et al.  Effect of high glucose on permeability of retinal capillary endothelium in vitro. , 1997, Investigative ophthalmology & visual science.

[68]  D. DeMets,et al.  The Wisconsin epidemiologic study of diabetic retinopathy. II. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years. , 1984, Archives of ophthalmology.

[69]  P. Raskin,et al.  Progression of diabetic retinopathy after pancreas transplantation. , 1988, The New England journal of medicine.

[70]  D L DeMets,et al.  The Wisconsin Epidemiologic Study of Diabetic Retinopathy. VI. Retinal photocoagulation. , 1987, Ophthalmology.

[71]  B L Petrig,et al.  Laser Doppler velocimetry study of retinal circulation in diabetes mellitus. , 1986, Archives of ophthalmology.

[72]  R. Bucala,et al.  Tobacco smoke is a source of toxic reactive glycation products. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[73]  E. Agardh,et al.  The glutathione levels are reduced in Goto-Kakizaki rat retina, but are not influenced by aminoguanidine treatment. , 1998, Current eye research.

[74]  Alan W. Stitt,et al.  The combined effects of diabetes and ionising radiation on the rat retina: an ultrastructural study. , 1994, Current eye research.

[75]  P. Colville-Nash,et al.  Growth factors in angiogenesis: current interest and therapeutic potential. , 1997, Molecular medicine today.

[76]  J. Fiddes,et al.  Capillary endothelial cells express basic fibroblast growth factor, a mitogen that promotes their own growth , 1987, Nature.

[77]  D. Ingber,et al.  A heparin-binding angiogenic protein--basic fibroblast growth factor--is stored within basement membrane. , 1988, The American journal of pathology.

[78]  M. Gillies,et al.  High glucose inhibits retinal capillary pericyte contractility in vitro. , 1993, Investigative ophthalmology & visual science.

[79]  M. Boulton,et al.  Intravitreal growth factors in proliferative diabetic retinopathy: correlation with neovascular activity and glycaemic management , 1997, The British journal of ophthalmology.

[80]  H. Suzuki,et al.  Ocular vascular endothelial growth factor levels in diabetic rats are elevated before observable retinal proliferative changes , 1997, Diabetologia.

[81]  P. D'Amore,et al.  Mechanisms of retinal and choroidal neovascularization. , 1994, Investigative ophthalmology & visual science.

[82]  G. King,et al.  Diabetic vascular dysfunctions: a model of excessive activation of protein kinase C. , 1997, Kidney international. Supplement.

[83]  Alan W. Stitt,et al.  Retinal vascular endothelial cell endocytosis increases in early diabetes. , 1995, Laboratory investigation; a journal of technical methods and pathology.

[84]  Joan W. Miller,et al.  Systemic hyperoxia decreases vascular endothelial growth factor gene expression in ischemic primate retina. , 1997, Archives of ophthalmology.

[85]  H. Freyberger,et al.  Vitreous levels of the insulin-like growth factors I and II, and the insulin-like growth factor binding proteins 2 and 3, increase in neovascular eye disease. Studies in nondiabetic and diabetic subjects. , 1993, The Journal of clinical investigation.

[86]  R. Klein,et al.  Cigarette smoking and ten-year progression of diabetic retinopathy. , 1996, Ophthalmology.

[87]  J. Skou,et al.  [1] Overview: The Na,K-pump , 1988 .

[88]  E. Kohner,et al.  Toxic action of advanced glycation end products on cultured retinal capillary pericytes and endothelial cells: relevance to diabetic retinopathy , 1997, Diabetologia.

[89]  T. Hohman,et al.  An aldose reductase inhibitor and aminoguanidine prevent vascular endothelial growth factor expression in rats with long-term galactosemia. , 1997, Archives of ophthalmology.

[90]  C. Zucker,et al.  Expression of vascular endothelial growth factor in the human retina and in nonproliferative diabetic retinopathy. , 1998, The American journal of pathology.

[91]  S. Bursell,et al.  Vitamin E prevents diabetes-induced abnormal retinal blood flow via the diacylglycerol-protein kinase C pathway. , 1995, The American journal of physiology.

[92]  L. Aiello,et al.  Vascular endothelial growth factor in ocular neovascularization and proliferative diabetic retinopathy. , 1997, Diabetes/metabolism reviews.

[93]  E. Kohner,et al.  Oxygen reactivity in diabetes mellitus: effect of hypertension and hyperglycaemia. , 1994, Clinical science.

[94]  E. Kohner,et al.  Autoregulation of retinal blood flow in diabetic retinopathy measured by the blue-light entoptic technique. , 1987, Ophthalmology.

[95]  H. Meiselman,et al.  Decreased Deformability of Polymorphonuclear Leukocytes in Diabetic Cats , 1996, Microcirculation.

[96]  J. Bernhagen,et al.  An agent cleaving glucose-derived protein crosslinks in vitro and in vivo , 1996, Nature.

[97]  D. R. Anderson,et al.  Effect of CO2 on intracellular pH and contraction of retinal capillary pericytes. , 1997, Investigative ophthalmology & visual science.

[98]  E. Cagliero,et al.  Fibronectin overexpression in retinal microvessels of patients with diabetes. , 1996, Investigative ophthalmology & visual science.

[99]  J. Nyengaard,et al.  Hyperglycemic Pseudohypoxia and Diabetic Complications , 1993, Diabetes.

[100]  D. R. Anderson,et al.  Relaxation of retinal pericyte contractile tone through the nitric oxide-cyclic guanosine monophosphate pathway. , 1994, Investigative ophthalmology & visual science.

[101]  J. Nyengaard,et al.  Elevated glucose levels increase retinal glycolysis and sorbitol pathway metabolism. Implications for diabetic retinopathy. , 1995, Investigative ophthalmology & visual science.

[102]  E. Kohner,et al.  Retinal blood flow in diabetic retinopathy. , 1992, BMJ.

[103]  D. Weinberger,et al.  Non-retinovascular leakage in diabetic maculopathy. , 1995, The British journal of ophthalmology.

[104]  A. Kashiwagi,et al.  Impaired Activation of Glucose Oxidation and NADPH Supply in Human Endothelial Cells Exposed to H2O2 in High-Glucose Medium , 1995, Diabetes.

[105]  H. Lodish,et al.  Molecular Physiology of Glucose Transporters , 1990, Diabetes Care.

[106]  J. Forrester,et al.  Glucose-dependent regulation of DNA synthesis in bovine retinal endothelial cells. , 1998, Current eye research.

[107]  C. Riva,et al.  Effect of an insulin-induced decrease in blood glucose on the human diabetic retinal circulation. , 1987, Ophthalmology.

[108]  G. Carmignoto,et al.  Nerve growth factor promotes functional recovery of retinal ganglion cells after ischemia. , 1993, Investigative ophthalmology & visual science.

[109]  R. Klein,et al.  The 14-year incidence of visual loss in a diabetic population. , 1998, Ophthalmology.

[110]  D. Hatchell,et al.  Neutrophils plug capillaries in acute experimental retinal ischemia. , 1994, Microvascular research.

[111]  Richard Wise,et al.  Science, medicine, and the future , 1998 .

[112]  J. Forrester,et al.  Role of glucose regulatory mechanisms in diabetic retinopathy. , 1995, The British journal of ophthalmology.

[113]  D. Green,et al.  The central executioners of apoptosis: caspases or mitochondria? , 1998, Trends in cell biology.

[114]  Alan W. Stitt,et al.  Diabetic retinopathy: quantitative variation in capillary basement membrane thickening in arterial or venous environments. , 1994, The British journal of ophthalmology.

[115]  D. Puro,et al.  Expression of transforming growth factor-beta s and their receptors by human retinal glial cells. , 1998, Current eye research.

[116]  Alan W. Stitt,et al.  Constitutive nitric oxide synthase expression in retinal vascular endothelial cells is suppressed by high glucose and advanced glycation end products. , 1998, Diabetes.

[117]  J. Cunha-Vaz,et al.  Effect of Sorbinil on Blood-Retinal Barrier in Early Diabetic Retinopathy , 1986, Diabetes.

[118]  L. Aiello,et al.  Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. , 1994, The New England journal of medicine.

[119]  A. Wyllie,et al.  Apoptosis: A Basic Biological Phenomenon with Wide-ranging Implications in Tissue Kinetics , 1972, British Journal of Cancer.

[120]  S. O’Rahilly,et al.  Science, medicine, and the future Non-insulin dependent diabetes mellitus: the gathering storm , 1997, BMJ.

[121]  M. R. Petersen,et al.  Progression of diabetic retinopathy after pancreas transplantation. The University of Michigan Pancreas Transplant Evaluation Committee. , 1990, Ophthalmology.

[122]  H Lestradet,et al.  [The discovery of insulin]. , 1996, Bulletin de l'Academie nationale de medecine.

[123]  S. Bursell,et al.  Regulation of retinal hemodynamics in diabetic rats by increased expression and action of endothelin-1. , 1996, Investigative ophthalmology & visual science.

[124]  Alan W. Stitt,et al.  Increased Levels of Advanced Glycation Endproducts in the Lenses and Blood Vessels of Cigarette Smokers , 1998, Molecular medicine.

[125]  N. Laver,et al.  The role of aldose reductase in diabetic retinopathy: Prevention and intervention studies , 1995, Progress in Retinal and Eye Research.

[126]  Joan W. Miller,et al.  Vascular endothelial growth factor/vascular permeability factor is temporally and spatially correlated with ocular angiogenesis in a primate model. , 1994, The American journal of pathology.

[127]  J. Williamson,et al.  Vascular dysfunction induced by elevated glucose levels in rats is mediated by vascular endothelial growth factor. , 1997, The Journal of clinical investigation.

[128]  Y. Ogura,et al.  Role of leukocytes in diabetic microcirculatory disturbances. , 1997, Microvascular research.

[129]  B. V. von Specht,et al.  Induction of neoangiogenesis in ischemic myocardium by human growth factors: first clinical results of a new treatment of coronary heart disease. , 1998, Circulation.

[130]  J. Stone,et al.  Role of astrocytes in the control of developing retinal vessels. , 1997, Investigative ophthalmology & visual science.

[131]  D. Goeddel,et al.  Vascular endothelial growth factor is a secreted angiogenic mitogen. , 1989, Science.

[132]  S. Cousins,et al.  Prevention of experimental proliferative vitreoretinopathy with a biodegradable intravitreal implant for the sustained release of fluorouracil. , 1994, Archives of ophthalmology.

[133]  M. Catherwood,et al.  Glucose-induced oxidative stress in vascular contractile cells: comparison of aortic smooth muscle cells and retinal pericytes. , 1998, Diabetes.

[134]  H. Kolb,et al.  Histochemical demonstration of glycogen in neurons of the cat retina. , 1996, Investigative ophthalmology & visual science.

[135]  E S Gragoudas,et al.  Inhibition of vascular endothelial growth factor prevents retinal ischemia-associated iris neovascularization in a nonhuman primate. , 1996, Archives of ophthalmology.

[136]  R. Bucala,et al.  Pathogenic effects of advanced glycosylation: biochemical, biologic, and clinical implications for diabetes and aging. , 1994, Laboratory investigation; a journal of technical methods and pathology.

[137]  F Jung,et al.  Retinal microcirculation in patients with diabetes mellitus: dynamic and morphological analysis of perifoveal capillary network. , 1991, The British journal of ophthalmology.

[138]  K. Chalam,et al.  Increased level of vascular endothelial growth factor in aqueous humor of patients with neovascular glaucoma. , 1998, Ophthalmology.

[139]  D. L. Fry Certain Histological and Chemical Responses of the Vascular Interface to Acutely Induced Mechanical Stress in the Aorta of the Dog , 1969, Circulation research.

[140]  A. Eller,et al.  ANTIHISTAMINES REDUCE BLOODRETINAL BARRIER PERMEABILITY IN TYPE I (INSULIN-DEPENDENT) DIABETIC PATIENTS WITH NONPROLIFERATIVE RETINOPATHY: A Pilot Study , 1995, Retina.

[141]  M. Gimbrone,et al.  Influence of hemodynamic forces on vascular endothelial function. In vitro studies of shear stress and pinocytosis in bovine aortic cells. , 1984, The Journal of clinical investigation.

[142]  H. Hammes,et al.  Upregulation of the vascular endothelial growth factor/vascular endothelial growth factor receptor system in experimental background diabetic retinopathy of the rat. , 1998, Diabetes.

[143]  M. Lorenzi,et al.  Increased expression of basement membrane collagen in human diabetic retinopathy. , 1994, The Journal of clinical investigation.

[144]  R. Linsenmeier,et al.  Retinal hypoxia in long-term diabetic cats. , 1998, Investigative ophthalmology & visual science.

[145]  J. Folkman,et al.  Increased Vascular Endothelial Growth Factor Levels in the Vitreous of Eyes With Proliferative Diabetic Retinopathy , 1995 .

[146]  C. Riva,et al.  Retinal hemodynamics in proliferative diabetic retinopathy. A laser Doppler velocimetry study. , 1993, Investigative ophthalmology & visual science.

[147]  D TOUSSAINT,et al.  Retinal vascular patterns. IV. Diabetic retinopathy. , 1961, Archives of ophthalmology.

[148]  J S Tiedeman,et al.  Retinal oxygen consumption during hyperglycemia in patients with diabetes without retinopathy. , 1998, Ophthalmology.

[149]  B. Margetts United Kingdom prospective diabetes study , 1995, BMJ.

[150]  Hidehiro Ishii,et al.  Vascular Endothelial Growth Factor–Induced Retinal Permeability Is Mediated by Protein Kinase C In Vivo and Suppressed by an Orally Effective β-Isoform–Selective Inhibitor , 1997, Diabetes.

[151]  G. Jaffe,et al.  An intravitreal sustained-release triamcinolone and 5-fluorouracil codrug in the treatment of experimental proliferative vitreoretinopathy. , 1998, Archives of ophthalmology.

[152]  Alan W. Stitt,et al.  Selective loss of vascular smooth muscle cells in the retinal microcirculation of diabetic dogs. , 1994, The British journal of ophthalmology.

[153]  S. Bursell,et al.  Normalization of Diacylglycerol-Protein Kinase C Activation by Vitamin E in Aorta of Diabetic Rats and Cultured Rat Smooth Muscle Cells Exposed to Elevated Glucose Levels , 1994, Diabetes.

[154]  B. Petrig,et al.  Altered retinal vascular response to 100% oxygen breathing in diabetes mellitus. , 1984, Ophthalmology.

[155]  L. Mandarino Current Hypotheses for the Biochemical Basis of Diabetic Retinopathy , 1992, Diabetes Care.

[156]  Aminoguanidine treatment inhibits the development of experimental diabetic retinopathy. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[157]  A. Vinik,et al.  Progression of Diabetic Retionopathy after Pancreas Transplantation , 1990 .

[158]  B. Hering,et al.  Recent Achievements in Experimental and Clinical Islet Transplantation , 1991, Diabetic medicine : a journal of the British Diabetic Association.

[159]  K. Tracey,et al.  Advanced glycosylation products quench nitric oxide and mediate defective endothelium-dependent vasodilatation in experimental diabetes. , 1991, The Journal of clinical investigation.

[160]  J. Stone,et al.  Development of retinal vasculature is mediated by hypoxia-induced vascular endothelial growth factor (VEGF) expression by neuroglia , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[161]  B. Gallacher,et al.  Glucose-Induced Protein Kinase C Activation Regulates Vascular Permeability Factor mRNA Expression and Peptide Production by Human Vascular Smooth Muscle Cells In Vitro , 1997, Diabetes.

[162]  M. Pfeifer,et al.  Aldose Reductase Inhibitors: The End of an Era or the Need for Different Trial Designs? , 1997, Diabetes.

[163]  Toyoshi Inoguchi,et al.  Induction of Resistance to Endothelin-1's Biochemical Actions by Elevated Glucose Levels in Retinal Pericytes , 1992, Diabetes.

[164]  Alan W. Stitt,et al.  Characterization of the advanced glycation end-product receptor complex in human vascular endothelial cells. , 1999, Biochemical and biophysical research communications.

[165]  G. Brown,et al.  Basic fibroblast growth factor levels in the vitreous of patients with proliferative diabetic retinopathy. , 1990, Archives of ophthalmology.

[166]  Alan W. Stitt,et al.  Advanced glycation end products (AGEs) co-localize with AGE receptors in the retinal vasculature of diabetic and of AGE-infused rats. , 1997, The American journal of pathology.

[167]  B. Petrig,et al.  Diabetic Glycemic Control and Retinal Blood Flow , 1990, Diabetes.

[168]  D L DeMets,et al.  The Wisconsin epidemiologic study of diabetic retinopathy. III. Prevalence and risk of diabetic retinopathy when age at diagnosis is 30 or more years. , 1984, Archives of ophthalmology.

[169]  D. Greene,et al.  Sorbitol, phosphoinositides, and sodium-potassium-ATPase in the pathogenesis of diabetic complications. , 1987, The New England journal of medicine.

[170]  T. Merimee,et al.  Diabetic retinopathy. A synthesis of perspectives. , 1990, The New England journal of medicine.

[171]  D. Archer,et al.  A morphologic and autoradiographic study of cell death and regeneration in the retinal microvasculature of normal and diabetic rats. , 1985, American journal of ophthalmology.

[172]  S. Bursell,et al.  Specific retinal diacylglycerol and protein kinase C beta isoform modulation mimics abnormal retinal hemodynamics in diabetic rats. , 1997, Investigative ophthalmology & visual science.

[173]  K Miyamoto,et al.  In vivo demonstration of increased leukocyte entrapment in retinal microcirculation of diabetic rats. , 1998, Investigative ophthalmology & visual science.

[174]  Mara,et al.  High glucose induces DNA damage in cultured human endothelial cells. , 1986, The Journal of clinical investigation.

[175]  Stephen J. Aldington,et al.  United Kingdom Prospective Diabetes Study, 30: diabetic retinopathy at diagnosis of non-insulin-dependent diabetes mellitus and associated risk factors. , 1998, Archives of ophthalmology.

[176]  T. Kern,et al.  Aldose Reductase Inhibition Fails to Prevent Retinopathy in Diabetic and Galactosemic Dogs , 1993, Diabetes.

[177]  T. Kern,et al.  Retinopathy in animal models of diabetes. , 1995, Diabetes/metabolism reviews.

[178]  Robertson Rp Seminars in medicine of the Beth Israel Hospital, Boston: Pancreatic and islet transplantation for diabetes--cures or curiosities? , 1992 .

[179]  Joan W. Miller,et al.  Intravitreous injections of vascular endothelial growth factor produce retinal ischemia and microangiopathy in an adult primate. , 1996, Ophthalmology.

[180]  Alan W. Stitt,et al.  Expression of vascular endothelial growth factor (VEGF) and its receptors is regulated in eyes with intra‐ocular tumours , 1998, The Journal of pathology.

[181]  R. Vracko,et al.  Manifestations of diabetes mellitus--their possible relationships to an underlying cell defect. A review. , 1974, The American journal of pathology.

[182]  L. Aiello,et al.  Adenosine mediates hypoxic induction of vascular endothelial growth factor in retinal pericytes and endothelial cells. , 1996, Investigative ophthalmology & visual science.

[183]  D. Wagner,et al.  P-selectin, a granule membrane protein of platelets and endothelial cells, follows the regulated secretory pathway in AtT-20 cells , 1992, The Journal of cell biology.

[184]  T. Hohman,et al.  Diabetic-like retinopathy: early and late intervention therapies in galactose-fed rats. , 1998, Investigative ophthalmology & visual science.

[185]  E. Keshet,et al.  Hypoxia-induced expression of vascular endothelial growth factor by retinal cells is a common factor in neovascularizing ocular diseases. , 1995, Laboratory investigation; a journal of technical methods and pathology.

[186]  N. Ruderman,et al.  Endothelium-dependent inhibition of Na(+)-K+ ATPase activity in rabbit aorta by hyperglycemia. Possible role of endothelium-derived nitric oxide. , 1992, The Journal of clinical investigation.

[187]  A. Cerami,et al.  Aminoguanidine prevents diabetes-induced arterial wall protein cross-linking. , 1986, Science.

[188]  S. Chakrabarti,et al.  Endothelin-1 and endothelin-3-like immunoreactivity in the eyes of diabetic and non-diabetic BB/W rats. , 1997, Diabetes research and clinical practice.

[189]  Philip D. Harvey,et al.  Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38 , 1998, BMJ.

[190]  M. Karmazyn,et al.  Augmented retinal endothelin-1, endothelin-3, endothelinA and endothelinB gene expression in chronic diabetes. , 1998, Current eye research.

[191]  Alan W. Stitt,et al.  Histological and ultrastructural investigation of retinal microaneurysm development in diabetic patients. , 1995, The British journal of ophthalmology.

[192]  D. Hatchell,et al.  Alterations in stimulus-induced integrin expression in peripheral blood neutrophils of patients with diabetic retinopathy. , 1997, The American journal of the medical sciences.

[193]  L. Aiello,et al.  Vascular endothelial growth factor-induced retinal permeability is mediated by protein kinase C in vivo and suppressed by an orally effective beta-isoform-selective inhibitor. , 1998, Diabetes.

[194]  P A D'Amore,et al.  Inhibition of capillary endothelial cell growth by pericytes and smooth muscle cells , 1987, The Journal of cell biology.

[195]  T. Lyons Glycation, oxidation, and glycoxidation reactions in the development of diabetic complications. , 1995, Contributions to nephrology.

[196]  E. Cagliero,et al.  Increased expression of basement membrane components in human endothelial cells cultured in high glucose. , 1988, The Journal of clinical investigation.

[197]  E. Leite,et al.  Characterization of the Early Stages of Diabetic Retinopathy by Vitreous Fluorophotometry , 1985, Diabetes.

[198]  A. Donker,et al.  Endothelial dysfunction and pathogenesis of diabetic angiopathy. , 1997, Cardiovascular research.

[199]  H. Inomata,et al.  Ultrastructure of retinal vessels in diabetic patients. , 1993, The British journal of ophthalmology.

[200]  M. Tsacopoulos,et al.  Nitric oxide controls arteriolar tone in the retina of the miniature pig. , 1995, Investigative ophthalmology & visual science.

[201]  Gardner Tw Histamine, ZO-1 and increased blood-retinal barrier permeability in diabetic retinopathy. , 1995 .

[202]  Lois E. H. Smith,et al.  Oligodeoxynucleotides inhibit retinal neovascularization in a murine model of proliferative retinopathy. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[203]  G. Lutty,et al.  Vascular endothelial growth factor and vascular permeability changes in human diabetic retinopathy. , 1997, Investigative ophthalmology & visual science.

[204]  G. Paolisso,et al.  Oxidative Stress and Diabetic Vascular Complications , 1996, Diabetes Care.

[205]  Alan W. Stitt,et al.  The 67-kd laminin receptor is preferentially expressed by proliferating retinal vessels in a murine model of ischemic retinopathy. , 1998, The American journal of pathology.

[206]  Hypoglycemia in the Diabetes Control and Complications Trial. The Diabetes Control and Complications Trial Research Group. , 1997, Diabetes.

[207]  B. Glasgow,et al.  GLUT1 glucose transporter expression in the diabetic and nondiabetic human eye. , 1994, Investigative ophthalmology & visual science.

[208]  C E Riva,et al.  Retinal vascular autoregulation in diabetes mellitus. , 1982, Ophthalmology.

[209]  B. Glaser Extracellular modulating factors and the control of intraocular neovascularization. An overview. , 1988, Archives of ophthalmology.

[210]  W. Schwarz,et al.  Structure-function relationships of cation binding in the Na+/K(+)-ATPase. , 1993, Biochimica et biophysica acta.

[211]  R. Danis,et al.  Insulin-like growth factor-1 retinal microangiopathy in the pig eye. , 1997, Ophthalmology.

[212]  R. Folberg,et al.  Vascular endothelial growth factor upregulation in human central retinal vein occlusion. , 1998, Ophthalmology.

[213]  T. Gardner,et al.  Neural apoptosis in the retina during experimental and human diabetes. Early onset and effect of insulin. , 1998, The Journal of clinical investigation.

[214]  G T Feke,et al.  Retinal circulatory abnormalities in type 1 diabetes. , 1994, Investigative ophthalmology & visual science.

[215]  J. Folkman,et al.  Synergistic effects of vascular endothelial growth factor and basic fibroblast growth factor on the proliferation and cord formation of bovine capillary endothelial cells within collagen gels. , 1993, Laboratory investigation; a journal of technical methods and pathology.

[216]  D. R. Anderson,et al.  Adenosine-induced relaxation of cultured bovine retinal pericytes. , 1997, Investigative ophthalmology & visual science.

[217]  M. Jacobson,et al.  Measurement of adenosine concentration in aqueous and vitreous. , 1998, Investigative ophthalmology & visual science.

[218]  T. Hohman,et al.  Diabetic-like retinopathy ameliorated with the aldose reductase inhibitor WAY-121,509. , 1996, Investigative ophthalmology & visual science.

[219]  K. Kinzler,et al.  A model for p53-induced apoptosis , 1997, Nature.

[220]  R. Danis,et al.  Inhibition of intraocular neovascularization caused by retinal ischemia in pigs by PKCbeta inhibition with LY333531. , 1998, Investigative ophthalmology & visual science.

[221]  J. Lingrel Na,K-ATPase: Isoform structure, function, and expression , 1992, Journal of bioenergetics and biomembranes.

[222]  R. Klein,et al.  Ten-year incidence of visual loss in a diabetic population. , 1994, Ophthalmology.

[223]  Y. Nishizuka,et al.  The role of protein kinase C in transmembrane signalling. , 1986, Annual review of cell biology.